Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
4,571.20
-1.00 (-0.02%)
Jun 12, 2026, 3:29 PM IST
Torrent Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,548,371 | 1,428,460 | 1,094,736 | 880,347 | 520,309 | 473,197 | |
Market Cap Growth | 44.18% | 30.48% | 24.35% | 69.20% | 9.96% | 10.04% |
Enterprise Value | 1,767,038 | 1,448,740 | 1,113,646 | 917,337 | 553,029 | 510,577 |
Last Close Price | 4571.20 | 4211.83 | 3193.54 | 2547.60 | 1486.94 | 1327.18 |
PE Ratio | 71.57 | 66.03 | 57.28 | 53.15 | 41.78 | 60.89 |
PS Ratio | 11.08 | 10.22 | 9.51 | 8.21 | 5.41 | 5.56 |
PB Ratio | 8.81 | 8.12 | 14.42 | 12.84 | 8.40 | 7.95 |
P/TBV Ratio | - | - | 36.63 | 45.49 | 67.48 | 22.04 |
P/FCF Ratio | 66.02 | 60.91 | 55.48 | 31.07 | 29.00 | 29.57 |
P/OCF Ratio | 51.22 | 47.26 | 42.35 | 26.95 | 21.97 | 26.25 |
EV/Sales Ratio | 12.64 | 10.36 | 9.67 | 8.55 | 5.75 | 6.00 |
EV/EBITDA Ratio | 38.89 | 32.22 | 30.30 | 27.59 | 19.73 | 21.43 |
EV/EBIT Ratio | 51.37 | 42.12 | 38.06 | 35.66 | 25.84 | 28.86 |
EV/FCF Ratio | 75.34 | 61.77 | 56.44 | 32.38 | 30.82 | 31.90 |
Debt / Equity Ratio | 0.85 | 0.85 | 0.43 | 0.59 | 0.87 | 0.69 |
Debt / EBITDA Ratio | 3.31 | 3.31 | 0.88 | 1.21 | 1.92 | 1.70 |
Debt / FCF Ratio | 6.41 | 6.41 | 1.65 | 1.43 | 3.02 | 2.57 |
Net Debt / Equity Ratio | 0.72 | 0.72 | 0.34 | 0.44 | 0.76 | 0.59 |
Net Debt / EBITDA Ratio | 2.82 | 2.82 | 0.70 | 0.91 | 1.67 | 1.48 |
Net Debt / FCF Ratio | 5.40 | 5.40 | 1.30 | 1.07 | 2.62 | 2.20 |
Asset Turnover | 0.47 | 0.47 | 0.77 | 0.71 | 0.68 | 0.63 |
Inventory Turnover | 1.19 | 1.19 | 1.15 | 1.19 | 1.17 | 0.95 |
Quick Ratio | 0.72 | 0.72 | 0.62 | 0.59 | 0.54 | 0.56 |
Current Ratio | 1.13 | 1.13 | 1.19 | 1.03 | 0.98 | 1.20 |
Return on Equity (ROE) | 16.99% | 16.99% | 26.46% | 25.38% | 20.50% | 13.18% |
Return on Assets (ROA) | 7.25% | 7.25% | 12.17% | 10.69% | 9.52% | 8.14% |
Return on Invested Capital (ROIC) | 12.57% | 12.67% | 20.88% | 17.43% | 14.16% | 11.50% |
Return on Capital Employed (ROCE) | 9.60% | 9.60% | 28.50% | 26.70% | 22.40% | 20.40% |
Earnings Yield | 1.40% | 1.51% | 1.75% | 1.88% | 2.39% | 1.64% |
FCF Yield | 1.51% | 1.64% | 1.80% | 3.22% | 3.45% | 3.38% |
Dividend Yield | 0.83% | 0.90% | 1.00% | 1.10% | 1.48% | 1.24% |
Payout Ratio | 59.58% | 59.58% | 56.67% | 61.30% | 41.21% | 87.10% |
Total Shareholder Return | 0.83% | 0.90% | 1.00% | 1.10% | 1.48% | 1.24% |